Grekin Skin Institute

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Psoriasis3 trials
• Atopic dermatitis (eczema)1 trial
• Vitiligo1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Alumis Inc2 trials
• Avita Medical1 trial
• RAPT Therapeutics, Inc., a member of the GSK plc group of companies1 trial
• Takeda1 trial

Running trials

• Active, not recruiting

  Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

  NCT06846541· Phase 3· Alumis Inc· Source

Closed trials

• Completed

  A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

  NCT06588738· Phase 3· Alumis Inc· Source

• Completed

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

  NCT06088043· Phase 3· Takeda· Source

• Completed

  Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

  NCT05971381· Avita Medical· Source

• Terminated

  An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

  NCT05399368· Phase 2· RAPT Therapeutics, Inc., a member of the GSK plc group of companies· Source